For twenty years, the human immunodeficiency virus (HIV) has been thwarting the attempts of scientists to develop an effective vaccine. Scientists are seeing major promise in the latest batch, so much promise that major pharmaceutical company GlaxoSmithKline is making deals.
Comments (0)
Please sign in to leave a comment.
No comments yet. Be the first to comment!